Cost-Effectiveness of Ponatinib in The Treatment of Patients With Accelerated or Blast Phase - Chronic Myeloid Leukemia in Greece
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.219
https://www.valueinhealthjournal.com/article/S1098-3015(17)30553-3/fulltext
Title :
Cost-Effectiveness of Ponatinib in The Treatment of Patients With Accelerated or Blast Phase - Chronic Myeloid Leukemia in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30553-3&doi=10.1016/j.jval.2017.08.219
First page :
A436
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
198